PLX
Protalix BioTherapeutics (PLX)
$03
About Protalix BioTherapeutics (PLX)
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Details
Daily high
$2.08
Daily low
$2.01
Price at open
$2.04
52 Week High
$3.10
52 Week Low
$1.32
Market cap
164.9M
Dividend yield
0.00%
Volume
210,239
Avg. volume
812,385
P/E ratio
29.50
Protalix BioTherapeutics News
Details
Daily high
$2.08
Daily low
$2.01
Price at open
$2.04
52 Week High
$3.10
52 Week Low
$1.32
Market cap
164.9M
Dividend yield
0.00%
Volume
210,239
Avg. volume
812,385
P/E ratio
29.50